Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA) for Guanfacine Hydrochloride extended release tablets 1mg, 2mg, 3mg and 4mg from the US FDA. Guanfacine Hydrochloride... Read more
Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Cooperation... Read more
Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic anti-coagulant... Read more
Bangalore: India-based Dr. Reddy's Laboratories has launched its montelukast sodium oral granules, a bioequivalent generic version of Singulair... Read more
Bangalore: The Intellectual Property Appellate Board in Chennai, India, has rejected pharma major Bayer's petition seeking a stay on compulsory... Read more
Singapore: India's Aurobindo Pharma received final approval from the US FDA to manufacture and market Escitalopram Oxalate tablets 5mg,... Read more
Singapore: Pfizer and China's Zhejiang Hisun Pharmaceuticals, a leading Chinese pharmaceutical company, announced the launch of Hisun-Pfizer... Read more
Mumbai: NATCO Pharma has filed a lawsuit against Mr Shamnaad Basheer, professor, West Bengal National University of Juridical Sciences,... Read more
Bangalore: India's generics giant Cipla has won a landmark patent case against Swiss drug maker Roche in the Delhi High Court. Roche had... Read more
Singapore: Pfizer has settled its litigation against Mylan and Mylan Pharmaceuticals relating to Pfizer's patents covering Detrol LA (tolterodine... Read more
Singapore: On July 9, 2012, the Generic Drug User Fee Amendments of 2012 (GDUFA) was enacted by the US. The Food and Drug Administration... Read more
Bangalore: The Supreme Court will take up the landmark case involving swiss drugmaker Novartis and India's patent office on September 11,... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
